Longevity in practice
Bryan Johnson Blueprint: the parts with evidence and the parts with a price tag
The Bryan Johnson Blueprint has cost about $2 million a year by his own published accounts, and it is both a genuine act of discipline and a supplement catalogue. Separating those two things is most of the work of reading it.
What does the Bryan Johnson Blueprint protocol actually contain?
A fixed daily routine of training, early eating, a rigid bedtime and dozens of supplements, which Johnson says has cost about $2 million a year in its full personal form.[1] The published Bryan Johnson Blueprint breaks into a few fixed blocks.
- A fixed wake time and a long morning workout mixing strength, cardio and flexibility.
- A compressed eating window, with the final meal in the early afternoon.
- An early and rigidly consistent bedtime.
- A supplement schedule running to dozens of items.
On top of that sits an extensive testing program, including regular bloodwork, imaging and epigenetic clock measurements.
It is worth stating plainly that the discipline involved is real. Very few people sustain a consistent sleep schedule and daily training for years. That part is not the problem, and anyone reading the Bryan Johnson Blueprint for ideas should credit it before criticizing anything else.
Can the protocol show which parts work?
Limited evidence No. It is an n-of-1 self-experiment with no control group, no blinding, hundreds of simultaneous variables and a design that changes whenever its participant decides to change it.[1] Every one of those is fatal to attribution on its own, and they are present together.
Consider what that means in practice. If a marker improves, the cause could be the diet, the training, the sleep, the absence of alcohol, one of the dozens of supplements, regression to the mean, measurement noise, or the fact that someone measuring themselves constantly behaves differently. The protocol cannot tell you which, and neither can anyone reading it.
Which parts of the protocol have real evidence?
The free ones. Regular sleep timing, daily aerobic and resistance exercise, a plant-heavy diet and avoiding alcohol are among the best-supported health behaviors in existence, with population-scale evidence behind each.
The one supplement with strong data
Creatine, one of the few supplements in the stack, has genuinely strong data for muscle and possibly cognitive benefit.[5]
What those items share is that they are free or nearly free, and that none of them is novel. The protocol's contribution is the consistency, not the discovery. Our guide to what the supplement evidence actually supports applies the same filter across the wider category.
Show the numbers as a table
| When | Event | Detail |
|---|---|---|
| 2013 | Epigenetic clock | Methylation age model |
| 2017 | Creatine stand | Safety and efficacy |
| 2019 | VITAL trial | Vitamin D, no benefit |
| 2023 | Hallmarks update | Twelve hallmarks |
| 2025 | Rapamycin review | Evidence insufficient |
Which parts lack evidence?
Most of the long tail of the supplement stack, where the evidence thins out fast. Many entries rest on cell studies or mouse work, several have known bioavailability problems, and a few have been tested in humans with disappointing results.
Large trials of individual supplements have repeatedly found less than expected, including the vitamin D and omega-3 arms of a very large randomized trial that reported no reduction in the primary endpoints.[7]
| Evidence | Participants | Design | What it can show |
|---|---|---|---|
| VITAL trial (Manson et al. 2019) | 25,871 | Randomized against placebo, median 5.3 years | Whether vitamin D changes the primary endpoints; it did not |
| Blueprint protocol (self-published) | 1 | No control, no blinding, inputs changed at will | That one person followed it; not which part did what |
Show the numbers as a table
| Measure | Value |
|---|---|
| VITAL trial | 25,871 people |
| Blueprint protocol | 1 person |
The imaging and testing schedule has a similar problem in a different form. Screening a healthy person without a clinical indication produces incidental findings that require follow-up, and there is no evidence that surveillance at that intensity improves outcomes in people who feel well.
Does Bryan Johnson still take rapamycin?
No. Johnson took rapamycin for several years and then publicly stopped, reporting that the side effects he experienced outweighed any benefit he could measure. Given his commitment to the compound and the visibility of the reversal, that is a genuinely useful data point.
It also aligns with where the evidence sits. Reviews of off-label use in healthy adults have concluded the clinical picture is insufficient to support routine use, and the risk profile is real even at intermittent doses.[3] [2] Our page on what actually changes at longevity doses covers that, and our main evidence guide covers the benefit side.
What do his biological age numbers mean?
Less than they appear to. The protocol leans heavily on epigenetic clocks and organ-age estimates, which are legitimate research tools built by regressing DNA methylation patterns against chronological age and health outcomes.[4] They are also noisy at the individual level, sensitive to short-term factors, and not validated as outcomes that predict how long a particular person will live.
How far a single clock reading can move
The noise has been measured, and it is large relative to the changes a single self-experimenter can expect to see.
- Across six prominent epigenetic clocks, replicate runs of the same DNA sample differed by up to 9 years from technical variation alone (per Higgins-Chen et al. 2022).[8]
- Retrained versions of those clocks brought most replicates within 1.5 years, which helps.
Even so, a before-and-after comparison on one person cannot cleanly separate a real change from measurement error.
So a favorable clock reading is a favorable clock reading. It is not a demonstration that aging has been slowed, and it certainly does not identify which of several hundred interventions produced it. Our page on what biological age tests can and cannot tell you goes through the measurement problem in detail.
You can split the same sample, run it twice, and get upwards of eight years difference in your epigenetic age.
Does Blueprint sell what the protocol recommends?
Yes: Blueprint is a company that sells the supplements described in the protocol. That does not make the protocol dishonest, but it does give it a commercial function. When the same page is both the record of an experiment and the storefront for its inputs, the incentive to keep items on the list is structural rather than personal.
Read it as you would read any manufacturer's account of its own products: worth reading, not sufficient on its own.
What should you actually copy from the protocol?
Copy the free parts: regular sleep timing, daily exercise, a plant-heavy diet and no alcohol, kept up for years. Skip the long supplement tail and the imaging schedule. The useful lesson from the Bryan Johnson Blueprint project is that boring consistency probably does more than any supplement in the catalogue.
The hallmarks framework that underpins most of these claims makes the same point when applied honestly: mechanisms are cheap, demonstrations are expensive, and almost nothing on a supplement shelf has one.[6]
Frequently asked questions
Can the consumer bundle reproduce what the $2 million version shows?
No. By his own accounts the full personal version pays for staff, imaging and continuous testing, while the consumer version is the supplement bundle alone. Whatever results are attributed to the first cannot be bought with the second.
Is Blueprint owned by Bryan Johnson?
Yes. Blueprint is both his personal protocol and his supplement company, and the two share a name and a website. That structure means the published protocol is also a product catalogue, which is worth holding in mind while reading it.
What does his rapamycin reversal tell a healthy adult considering it?
That close monitoring did not make the drug worth it for him: he stopped, reporting side effects that outweighed any benefit he could measure. Reviews of off-label use in healthy adults also find the evidence insufficient for routine use.
Is Bryan Johnson's blueprint worth it?
As a protocol to copy, mostly not. The parts with real evidence, sleep regularity, exercise, a plant-heavy diet, no alcohol, are free. The parts that cost money are the parts with the least evidence, and none of it has been tested against a control.
How much can a clock reading move with no real change in the body?
Up to 9 years. Replicate runs of the same DNA sample across six prominent epigenetic clocks differed by that much from technical variation alone, and retrained versions brought most replicates within 1.5 years (per Higgins-Chen et al. 2022).
Does one large trial outweigh one person's results?
For the question of whether a supplement works, yes. The VITAL trial randomized 25,871 people against placebo for a median of 5.3 years and found no reduction in its primary endpoints, while the protocol has one participant and no control.
Why can a protocol that keeps changing never test itself?
Because nothing is held constant. Dozens of supplements revised continuously by the only participant means no outcome can be tied to any component, however carefully it is measured.
Does the protocol actually make him age slower?
He reports epigenetic clock readings and organ-specific age estimates suggesting slower aging. Those measures are research tools with meaningful variability, they respond to short-term factors, and no clock has been validated as an outcome that predicts individual longevity.
What is the strongest criticism of Blueprint?
That it cannot generate knowledge. One person, no control group, hundreds of simultaneous interventions, outcomes measured by tools that were not designed to score individuals. Any result is uninterpretable, which is a design problem rather than an effort problem.
Is any of it worth copying?
Several things. Consistent sleep timing, daily exercise including both strength and cardio, a mostly plant diet, no alcohol, and actually measuring standard blood markers. None of that is novel and all of it is well supported.
What should someone skip?
The long tail of supplements with no human outcome data, the expensive imaging without a clinical indication, and anything justified by a mechanism rather than a result. That covers a large share of the spending.
Should a healthy person copy his imaging and testing schedule?
There is no evidence that it helps. Screening a healthy person without a clinical indication produces incidental findings that need follow-up, and surveillance at that intensity has not been shown to improve outcomes in people who feel well.
Is the biological age claim meaningful?
Partly. Some of his measured markers genuinely are better than population averages for his age, which is what you would expect from years of disciplined exercise, sleep and diet. Attributing them to the supplement stack rather than to those basics is the unsupported leap.
What is the honest summary?
A disciplined person doing several well-evidenced things extremely consistently, plus a large number of unevidenced things, selling the combination. The discipline is real and probably beneficial. The attribution is unresolvable by design.
References
8 sources, all link-checked; oldest check
- Blueprint protocol (self-published). Bryan Johnson.Primary/self-published source; n-of-1, not peer-reviewed.Verified Sep 15, 2026
- Rapamycin for longevity: the pros, the cons, and future perspectives. Roark KM, Iffland PH. Frontiers in Aging 2025;6:1628187.Peer-reviewed review, cited 31 times.Verified Sep 15, 2026
- What is the clinical evidence to support off-label rapamycin therapy in healthy adults?. Hands SL, Lustgarten MS, Frame AA, Rosen CJ. Aging (Albany NY) 2025.Publisher blocks automated checks · last tried Sep 15, 2026
- DNA methylation age of human tissues and cell types. Horvath S. Genome Biology 2013;14:R115.Verified Sep 15, 2026
- International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation. Kreider RB et al. Journal of the International Society of Sports Nutrition 2017;14:18.Verified Sep 15, 2026
- Hallmarks of aging: an expanding universe. López-Otín C et al. Cell 2023;186(2):243–278.Updated framework: twelve hallmarks.Publisher blocks automated checks · last tried Sep 15, 2026
- Vitamin D supplements and prevention of cancer and cardiovascular disease. Manson JE et al. New England Journal of Medicine 2019 (VITAL; cited 2,159).25,871 participants, median 5.3 years: vitamin D did not lower the incidence of invasive cancer or cardiovascular events versus placebo.Publisher blocks automated checks · last tried Sep 15, 2026
- A computational solution for bolstering reliability of epigenetic clocks. Higgins-Chen AT et al. Nature Aging 2022;2:644–661.Documents test–retest reliability limits of methylation clocks.Verified Sep 15, 2026
Every link above is re-requested on a schedule by an automated checker; the date shown is when it last answered. Publishers that block automated requests are marked as such rather than reported broken. Our editorial standards explain how a source gets cited here in the first place.
Filed by the Rapamycin.store evidence desk. Each source is re-checked when the page is reviewed.
Own a longevity or health brand?
Rapamycin.store publishes sponsored and guest posts on an aged, topically-relevant domain, and offers display advertising. Tell us what you want to promote and we'll send our current options.